company background image
BAI logo

BenevolentAI ENXTAM:BAI Stock Report

Last Price

€0.74

Market Cap

€90.7m

7D

1.9%

1Y

35.3%

Updated

02 Dec, 2024

Data

Company Financials +

BenevolentAI S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for BenevolentAI
Historical stock prices
Current Share Price€0.74
52 Week High€2.66
52 Week Low€0.46
Beta0.89
11 Month Change-3.38%
3 Month Change-6.77%
1 Year Change35.27%
33 Year Changen/a
5 Year Changen/a
Change since IPO-92.48%

Recent News & Updates

Is BenevolentAI (AMS:BAI) In A Good Position To Invest In Growth?

Sep 24
Is BenevolentAI (AMS:BAI) In A Good Position To Invest In Growth?

Recent updates

Is BenevolentAI (AMS:BAI) In A Good Position To Invest In Growth?

Sep 24
Is BenevolentAI (AMS:BAI) In A Good Position To Invest In Growth?

Is BenevolentAI (AMS:BAI) In A Good Position To Invest In Growth?

Jun 07
Is BenevolentAI (AMS:BAI) In A Good Position To Invest In Growth?

We're Keeping An Eye On BenevolentAI's (AMS:BAI) Cash Burn Rate

Dec 23
We're Keeping An Eye On BenevolentAI's (AMS:BAI) Cash Burn Rate

BenevolentAI S.A. (AMS:BAI) Analysts Just Trimmed Their Revenue Forecasts By 24%

Jun 22
BenevolentAI S.A. (AMS:BAI) Analysts Just Trimmed Their Revenue Forecasts By 24%

BenevolentAI S.A. (AMS:BAI) Analysts Just Cut Their EPS Forecasts Substantially

Apr 26
BenevolentAI S.A. (AMS:BAI) Analysts Just Cut Their EPS Forecasts Substantially

BenevolentAI S.A. (AMS:BAI) Analysts Just Slashed This Year's Revenue Estimates By 20%

Apr 08
BenevolentAI S.A. (AMS:BAI) Analysts Just Slashed This Year's Revenue Estimates By 20%

Will BenevolentAI société anonyme (AMS:BAI) Spend Its Cash Wisely?

Dec 10
Will BenevolentAI société anonyme (AMS:BAI) Spend Its Cash Wisely?

We're Keeping An Eye On BenevolentAI société anonyme's (AMS:BAI) Cash Burn Rate

Jul 23
We're Keeping An Eye On BenevolentAI société anonyme's (AMS:BAI) Cash Burn Rate

Shareholder Returns

BAINL PharmaceuticalsNL Market
7D1.9%0.8%0.6%
1Y35.3%6.6%7.7%

Return vs Industry: BAI exceeded the Dutch Pharmaceuticals industry which returned 6.6% over the past year.

Return vs Market: BAI exceeded the Dutch Market which returned 7.7% over the past year.

Price Volatility

Is BAI's price volatile compared to industry and market?
BAI volatility
BAI Average Weekly Movement7.5%
Pharmaceuticals Industry Average Movement5.3%
Market Average Movement4.1%
10% most volatile stocks in NL Market7.0%
10% least volatile stocks in NL Market2.3%

Stable Share Price: BAI's share price has been volatile over the past 3 months compared to the Dutch market.

Volatility Over Time: BAI's weekly volatility has decreased from 21% to 8% over the past year, but is still higher than 75% of Dutch stocks.

About the Company

FoundedEmployeesCEOWebsite
2013180n/awww.benevolent.com

BenevolentAI S.A. operates as a clinical-stage artificial intelligence (AI) enabled drug discovery and development company. Its Benevolent platform integrates AI and science to uncover and develop drugs for complex diseases. The company’s development pipeline includes BEN-8744, an oral phosphodiesterase 10 (PDE10) inhibitor under phase 1 study for the treatment of Ulcerative Colitis; BEN-28010, an oral brain penetrant CHK1 inhibitor under preclinical study for the treatment of Glioblastoma Multiforme; BEN-34712, a preclinical candidate for the potential treatment of ALS; and various candidates for the treatment of fibrosis and Parkinson’s disease.

BenevolentAI S.A. Fundamentals Summary

How do BenevolentAI's earnings and revenue compare to its market cap?
BAI fundamental statistics
Market cap€90.72m
Earnings (TTM)-€61.97m
Revenue (TTM)€5.87m

15.5x

P/S Ratio

-1.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BAI income statement (TTM)
RevenueUK£4.87m
Cost of RevenueUK£2.79m
Gross ProfitUK£2.08m
Other ExpensesUK£53.49m
Earnings-UK£51.41m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.42
Gross Margin42.77%
Net Profit Margin-1,056.02%
Debt/Equity Ratio0%

How did BAI perform over the long term?

See historical performance and comparison